Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company
01 October 2015
A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.
Related
-
Guitar maker’s German supplier says GDPR will cause US discovery delay
-
Steinhoff adds Lehman administrator as €12bn class action looms
-
Paul Weiss Rifkind Wharton & Garrison
-
Bankrupt helicopter-leasing company strikes sale agreement
-
Weil Gotshal & Manges advising as Sears files Chapter 11 in New York
Most Read
- Slaughter and May and Ashurst advising as Interserve seeks rescue plan
- Global oil group files for Chapter 15 recognition of Brazilian reorganisation
- Singapore blocks Noble stock re-listing
- Kenyan cement company looks to sell out of administration
- Canadian court approves DIP financing for telecoms company amid capital dispute
